Piper Sandler analyst Patrick Moley reiterates CME Gr (NASDAQ:CME) with a Overweight and maintains $225 price target.
Piper Sandler Reiterates Overweight on CME Gr, Maintains $225 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.